News
Every patient in the trial has met the primary safety endpoint, confirmed through PET imaging showing precise retention of the therapeutic Yttrium-90 isotope at the injection site—with no observed ...
Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing.
We tapped two board-certified dermatologists to get their expert insight on how to achieve fuller, juicier lips at home—no ...
Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
TAMPA, FL / ACCESS Newswire / April 8, 2025 / Dr. Thomas Rhee, a renowned sports chiropractor and medical innovator, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results